20-5922586-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001819.3(CHGB):āc.442G>Cā(p.Val148Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001819.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHGB | NM_001819.3 | c.442G>C | p.Val148Leu | missense_variant | 4/5 | ENST00000378961.9 | NP_001810.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHGB | ENST00000378961.9 | c.442G>C | p.Val148Leu | missense_variant | 4/5 | 1 | NM_001819.3 | ENSP00000368244 | P1 | |
CHGB | ENST00000455042.1 | c.382G>C | p.Val128Leu | missense_variant | 5/5 | 3 | ENSP00000416643 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250606Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135480
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461788Hom.: 0 Cov.: 57 AF XY: 0.00000550 AC XY: 4AN XY: 727186
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.442G>C (p.V148L) alteration is located in exon 4 (coding exon 4) of the CHGB gene. This alteration results from a G to C substitution at nucleotide position 442, causing the valine (V) at amino acid position 148 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at